Ramaswamy B - Search Results

1

Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients.

Ramaswamy B, Elias AD, Kelbick NT, Dodley A, Morrow M, Hauger M, Allen J, Rhoades C, Kendra K, Chen HX, Eckhardt SG, Shapiro CL. Ramaswamy B, et al. Clin Cancer Res. 2006 May 15;12(10):3124-9. doi: 10.1158/1078-0432.CCR-05-2603. Clin Cancer Res. 2006. PMID: 16707611 Clinical Trial.

2

Bisphosphonates in the prevention and treatment of bone metastases.

Ramaswamy B, Shapiro CL. Ramaswamy B, et al. Oncology (Williston Park). 2003 Sep;17(9):1261-70; discussion 1270-2, 1277-8, 1280. Oncology (Williston Park). 2003. PMID: 14569853 Free article. Review.

3

Phase II trial of bevacizumab in combination with docetaxel in women with advanced breast cancer.

Ramaswamy B, Shapiro CL. Ramaswamy B, et al. Clin Breast Cancer. 2003 Oct;4(4):292-4. doi: 10.3816/cbc.2003.n.035. Clin Breast Cancer. 2003. PMID: 14651775 Clinical Trial. No abstract available.

4

Osteopenia and osteoporosis in women with breast cancer.

Ramaswamy B, Shapiro CL. Ramaswamy B, et al. Semin Oncol. 2003 Dec;30(6):763-75. doi: 10.1053/j.seminoncol.2003.08.028. Semin Oncol. 2003. PMID: 14663777 Review.

5

Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer.

Ramaswamy B, Povoski SP, Rhoades C, Allen J, Hauger M, Young D, Burak W, Farrar W, Yee L, Kendra K, Somasundaram S, Orlowski RZ, Shapiro CL. Ramaswamy B, et al. Breast Cancer Res Treat. 2005 Sep;93(1):67-74. doi: 10.1007/s10549-005-3784-z. Breast Cancer Res Treat. 2005. PMID: 16184461 Clinical Trial.

6

Docetaxel: a tubulin-stabilizing agent approved for the management of several solid tumors.

Ramaswamy B, Puhalla S. Ramaswamy B, et al. Drugs Today (Barc). 2006 Apr;42(4):265-79. doi: 10.1358/dot.2006.42.4.968648. Drugs Today (Barc). 2006. PMID: 16703123 Review.

7

Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer.

Mrozek E, Ramaswamy B, Young D, Rhoades CA, Kendra K, Allen J, Moore T, Hauger M, Watson H, Merriman N, Nadella P, Villalona-Calero M, Shapiro CL. Mrozek E, et al. Among authors: ramaswamy b. Clin Breast Cancer. 2006 Jun;7(2):141-5. doi: 10.3816/CBC.2006.n.023. Clin Breast Cancer. 2006. PMID: 16800973 Clinical Trial.

8

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1.

Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL, Jacob S, Majumder S. Miller TE, et al. Among authors: ramaswamy b. J Biol Chem. 2008 Oct 31;283(44):29897-903. doi: 10.1074/jbc.M804612200. Epub 2008 Aug 15. J Biol Chem. 2008. PMID: 18708351 Free PMC article.

9

Docetaxel for the post-surgery treatment of patients with node-positive breast cancer.

Pant S, Chilukuri MP, Ramaswamy B. Pant S, et al. Among authors: ramaswamy b. Ther Clin Risk Manag. 2008 Apr;4(2):419-24. doi: 10.2147/tcrm.s1766. Ther Clin Risk Manag. 2008. PMID: 18728853 Free PMC article.

10

Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity.

Ramaswamy B, Majumder S, Roy S, Ghoshal K, Kutay H, Datta J, Younes M, Shapiro CL, Motiwala T, Jacob ST. Ramaswamy B, et al. Mol Endocrinol. 2009 Feb;23(2):176-87. doi: 10.1210/me.2008-0211. Epub 2008 Dec 18. Mol Endocrinol. 2009. PMID: 19095770 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters